Vifor Clinches Deal For Travere's Rare Kidney Disorder Drug

Pays $55m Upfront For Sparsentan

 
• By Kevin Grogan
  
Agreement business handshake partnership deal as a solution strategy with a team coming together out of tangled twisted roads on to a bridge to find a common goal.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Genitourinary

More from Therapeutic Category